Medications

FDA panel rejects combination pain pill

Federal health advisers have unanimously rejected an experimental pain pill that combines two common opioids, oxycodone and morphine.

Neuroscience

Study identifies new drug target for chronic, touch-evoked pain

(Medical Xpress)—Researchers at the School of Medicine have identified a subset of nerve cells that mediates a form of chronic, touch-evoked pain called tactile allodynia, a condition that is resistant to conventional pain ...

page 5 from 13